Toripalimab combined with gemcitabine and S-1 in the first-line treatment of advanced biliary tract cancer.
Wei Li(Xuzhou Medical College), Tianshu Liu(Sun Yat-sen University), Yiyi Yu(Sun Yat-sen University), Lujia Huang, Qing Hao(University of California, Los Angeles), Qian Li(Nanchang University), Yueqi Wang(Memorial Sloan Kettering Cancer Center), Xiaojing Xu(Central South University), Chenlu Zhang(Northwestern University), Houbao Liu(Sun Yat-sen University), Xi Guo(Zhongshan Hospital), Yan Wang(Sun Yat-sen University), Yuehong Cui
Cited by 3
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study
|The Lancet Neurology|2011|587